Kolexia
Charafe-Jauffret Emmanuelle
Anatomie et cytologie
Centre Paoli-Calmettes
Marseille, France
224 Activités
1.9 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Cancers du sein inflammatoires Tumeurs du sein triple-négatives Carcinomes Transformation cellulaire néoplasique Adénocarcinome Cellules tumorales circulantes Carcinome canalaire du sein

Industries

AstraZeneca
6 collaboration(s)
Dernière en 2022
EXACT SCIENCES FRANCE SAS
3 collaboration(s)
Dernière en 2022
Daiichi Sankyo
2 collaboration(s)
Dernière en 2022
VERACYTE
2 collaboration(s)
Dernière en 2022

Dernières activités

22P Predictive value of tertiary lymphoid structure in patients with mismatch repair deficient advanced/recurrent endometrial cancer treated with dostarlimab
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.
Cancer research   18 septembre 2023
Experimental and spontaneous metastasis assays can result in divergence in clonal architecture.
Communications biology   07 août 2023
MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.
British journal of cancer   13 juillet 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.
Cancer medicine   06 juillet 2023
Disruption of lineage integrity as a precursor to breast tumor initiation.
Trends in cell biology   14 avril 2023
Abstract 3239: Selective depletion of regulatory T cells by ALD2510, a novel IL-2-sparing anti-CD25 antibody, synergizes with PD-1 blockade in breast and gynecologic cancers
Proceedings: AACR Annual Meeting 2023   01 avril 2023
Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectors.
STAR protocols   19 janvier 2023
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate.
Molecular cancer therapeutics   06 juillet 2022
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation.
Cell   20 mai 2022